HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

IPL576,092

structure in first source

Also Known As:

IPL576092

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Cholestanes
      - Sterols: 2245
        IPL576,092: 2
Lipids: 114793
- Membrane Lipids: 1591
  - Sterols: 2245
    - IPL576,092: 2

Experts

1.	Abraham, W: 1 article (01/2004)
2.	Harris, P: 1 article (01/2004)
3.	Kasserra, C E: 1 article (01/2004)
4.	Langlands, J M: 1 article (01/2004)
5.	Stenton, G R: 1 article (01/2004)
6.	Burgoyne, David L: 1 article (05/2002)
7.	Shen, Yaping: 1 article (05/2002)

Related Diseases

1.	Respiratory Hypersensitivity 01/01/2004 - "Sheep were treated with IPL576,092 by inhalation (400 microg/kg/day), and lung resistance and airway hyper-responsiveness (AHR) were determined after Ascaris suum challenge. "
2.	Pneumonia (Pneumonitis) 01/01/2004 - "In a rat ovalbumin lung inflammation model, orally administered IPL576,092 significantly inhibited the challenge-mediated increase in total bronchoalveolar lavage leukocyte numbers, and macrophage and lymphocyte infiltration (1-10 mg/kg/day). "
3.	Inflammation (Inflammations) 01/01/2004 - "IPL576,092, a lead compound from a novel class of polyhydroxylated sterols, was tested in models of allergen-induced bronchoconstriction and airway inflammation. "
4.	Asthma (Bronchial Asthma) 05/31/2002 - "Efficient synthesis of IPL576,092: a novel anti-asthma agent."

Related Drugs and Biologics

1.	Sterols
2.	Ovalbumin
3.	Allergens